GlassScriptPhysician profile
Alice J Hirata
NPI 1760466684
$3,703.85
in general payments reported to CMS, 2019-2025
26 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $725 · 2020: $671 · 2021: $478 · 2022: $902 · 2023: $573 · 2024: $210 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $931.88 | 2019-2023 | |
| Minerva Surgical, INC | $368.98 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $303.34 | 2019-2024 | |
| Organon LLC | $238.12 | 2022-2024 | Nexplanon |
| Exeltis, USA INC. | $236.81 | 2020-2023 | Slynd |
| Myovant Sciences INC. | $227.01 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $203.82 | 2022-2025 | |
| Hologic Sales and Service, LLC | $193.13 | 2022-2025 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Therapeuticsmd, INC. | $140.65 | 2019-2022 | |
| Pfizer INC. | $131.29 | 2019-2023 | |
| Agile Therapeutics, INC. | $130.01 | 2021-2023 | Twirla |
| Merck Sharp & Dohme LLC | $103.34 | 2019-2021 | |
| Novo Nordisk INC | $100.54 | 2022-2023 | Wegovy |
| Duchesnay USA Incorporated | $64.58 | 2019 | |
| Lupin INC. | $44.43 | 2019-2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $36.27 | 2019 | |
| Coopersurgical, INC. | $35.30 | 2020-2023 | Wallach Cryosurgical Equipment |
| Astellas Pharma US INC | $34.84 | 2023 | Veozah |
| Davol INC. | $34.15 | 2023 | Arista Ah Flexitip |
| Covidien LP | $31.45 | 2019-2020 | |
| Exact Sciences Corporation | $24.13 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $21.08 | 2023 | Myfembree |
| Amgen INC. | $20.11 | 2020 | |
| Convatec INC. | $19.91 | 2024 | |
| Amag Pharmaceuticals, INC. | $17.83 | 2019 | |
| Allergan, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Hirata listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.